http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022323561-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b90d9b31a84fae4d2560a9313a7aa3bb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001129
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2022-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9eaf9cc35700f12b0dcf8d11a94c0f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9d81db1140431a31f487288cd5d2319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021f05bb4af193a1ecd4772d49d98360
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f41e658a605425a4ab16da36464ade
publicationDate 2022-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022323561-A1
titleOfInvention Antigenic Peptides For Prevention And Treatment Of B-Cell Malignancy
abstract The present invention relates to antigen-based immunotherapy, in particular cancer immunotherapy. In particular, the present invention provides antigenic peptides, which are distinct from, but have amino acid similarity to, especially share the same core sequence with epitopes of human tumor antigens. The present invention further provides immunogenic compounds, nanoparticles, cells and pharmaceutical compositions comprising such antigenic peptides and nucleic acids encoding such antigenic peptides.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712465-B2
priorityDate 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455588976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478796996

Total number of triples: 26.